Circadian rhythm of urinary potassium excretion during treatment with an angiotensin receptor blocker

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 509-514

  Ogiyama, Yoshiaki ^a   Miura, Toshiyuki ^a   Watanabe, Shuichi ^a   Fuwa, Daisuke ^a   Tomonari, Tatsuya ^a   Ota, Keisuke ^a   Kato, Yoko ^a   Ichikawa, Tadashi ^a   Shirasawa, Yuichi ^a   Ito, Akinori ^a   Yoshida, Atsuhiro ^a   Fukuda, Michio ^a   Kimura, Genjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

angiotensin receptor blocker; chronic kidney disease; Circadian rhythm; sodium; urinary potassium excretion

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; POTASSIUM; SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CORRELATIONAL STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; MALE; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; URINARY EXCRETION; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; URINE;

ANGIOTENSIN RECEPTOR ANTAGONISTS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; POTASSIUM; SODIUM;

EID: 84918545810     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313475909     Document Type: Article

References (28)

1. Bultasová H, Veselková A, Brodan V, et al. Circadian rhythms of urinary sodium, potassium and some agents influencing their excretion in young borderline hypertensives. Endocrinol Exp. 1986 ; 20: 359-369
2. Dyer AR, Martin GJ, Burton WN, et al. Blood pressure and diurnal variation in sodium, potassium, and water excretion. J Hum Hypertens. 1998 ; 12: 363-371
3. Dyer AR, Stamler R, Grimm R, et al. Do hypertensive patients have a different diurnal pattern of electrolyte excretion?. Hypertension. 1987 ; 10: 417-424
4. Kirkland JL, Lye M, Levy DW, et al. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J (Clin Res Ed). 1983 ; 287: 1665-1667
5. Miura T, Fukuda M, Naito T, et al. Circadian rhythm of urinary potassium excretion in patients with CKD. Clin Nephrol. 2012 ; 78: 169-173
6. Fukuda M, Munemura M, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int. 2004 ; 65: 621-625
7. Fukuda M, Motokawa M, Miyagi S, et al. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006 ; 21: 2172-2177
8. Fukuda M, Mizuno M, Yamanaka T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008 ; 52: 1155-1160
9. Fukuda M, Yamanaka T, Mizuno M, et al. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008 ; 26: 583-588
10. Fukuda M, Wakamatsu-Yamanaka T, Mizuno M, et al. Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption. Am J Physiol Renal Physiol. 2011 ; 301: F953 - F957
11. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002 ; 39: S1 - S266
12. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007 ; 25: 1751-1762
13. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009 ; 32: 3-107
14. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003: 42 1206-1252
15. Adamson AR, Jamieson SW. Urinary excretion of sodium and potassium in relation to plasma aldosterone concentration. J Endocrinol. 1972 ; 53: 425-431
16. Ethier JH, Kamel KS, Magner PO, et al. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990 ; 15: 309-315
17. Stanton BA. Renal potassium transport: Morphological and functional adaptations. Am J Physiol. 1989 ; 257: R989 - R997
18. Young DB. Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol. 1988 ; 255: F811 - F822
19. Garcia-Filho E, Malnic G, Giebisch G. Effects of changes in electrical potential difference on tubular potassium transport. Am J Physiol. 1980 ; 238: F235 - F246
20. Stokes JB. Sodium and potassium transport by the collecting duct. Kidney Int. 1990 ; 38: 679-686
21. Young DB, Paulsen AW. Interrelated effects of aldosterone and plasma potassium on potassium excretion. Am J Physiol. 1983 ; 244: F28 - F34
22. Kamel KS, Quaggin S, Scheich A, et al. Disorders of potassium homeostasis: An approach based on pathophysiology. Am J Kidney Dis. 1994 ; 24: 597-613
23. Beutler KT, Masilamani S, Turban S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension. 2003 ; 41: 1143-1150
24. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol. 2002 ; 13: 1131-1135
25. Rabinowitz L, Sarason RL, Yamauchi H. Effects of KCl infusion on potassium excretion in sheep. Am J Physiol. 1985 ; 249: F263 - F271
26. Lee FN, Oh G, McDonough AA, et al. Evidence for gut factor in K+ homeostasis. Am J Physiol Renal Physiol. 2007 ; 293: F541 - F547
27. Hené RJ, Boer P, Koomans HA, et al. Plasma aldosterone concentrations in chronic renal disease. Kidney Int. 1982 ; 21: 98-101
28. Bastl C, Hayslett JP, Binder HJ. Increased large intestinal secretion of potassium in renal insufficiency. Kidney Int. 1977 ; 12: 9-16